Media and Investors Resources
Kuros Interim Results, 2022
English version
Press Release, 9 August 2022
Adhoc Press Release
Kuros Biosciences reports results for the first six months of 2022
Minutes of the AGM, 8 June 2022
German version
Press Release, 8 June 2022
Adhoc Press Release
Annual General Meeting of Kuros Biosciences approves all resolutions
Press Release, 2 June 2022
Adhoc Press Release
Kuros Biosciences: Completion of the acquisition of Checkmate Pharmaceuticals by Regeneron Pharmaceuticals triggers a $5 million milestone payment
Press Release, 31 May 2022
Kuros Biosciences announces favorable preliminary results of MagnetOs as standalone alternative to autograft in first randomized controlled trial